Biotechnology
Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls
SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ -- Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A, Flu B, RSV A/B, and three different target genes of COVID-19 (S gene, RdRP gene and N ge...
Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Chronic Lymphocytic Leukemia
SUZHOU, China and ROCKVILLE, Md., Sept. 7, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...
Polygiene ViralOff proven effective against SARS-CoV-2
STOCKHOLM, Sept. 7, 2020 /PRNewswire/ -- In the first test ever using the ISO method* on the SARS-CoV-2 virus on textiles, Polygiene ViralOff® was confirmed the first commercial textiles treatment in the world to reduce the virus by over 99% over two hours. While this comes as no surprise to us, ...
RhoVac appoints Professor Georg Hollaender to its Scientific Advisory Board
STOCKHOLM, Sept. 4, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today September 4th 2020, that it is continuing to strengthen the Scientific Advisory Board with a pediatric immunologist, by appointing ProfessorGeorg Hollaender, Action Research Professor and Head of Department at Oxford ...
Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels
COTIGNOLA, Italy, Sept. 3, 2020 /PRNewswire/ -- Concept Medical Inc
George Clinical Adds CRO Business Development and Operations Veteran to Lead Efforts in China
OVERLAND PARK, Kansas, Sept. 3, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has expanded the organization's team inChina with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations. Zhenfei will...
BOI Says Investors Show Increasing Interest in Thailand's Medical Sector
BANGKOK, Sept. 2, 2020 /PRNewswire/ -- A growing number of international and
Thai companies are investing inThailand's medical to help address the COVID-19
situation as well as to build on the country's potential as a medical hub, the
Thailand's Board of Investment (BOI) said.
Humoral immune response to SARS-CoV2 in Iceland
Titers of antibodies against SARS-CoV2 do not decline within four months REYKJAVIK, Iceland, Sept. 2, 2020 /PRNewswire/ -- Scientists at deCODE genetics inIceland, a subsidiary of Amgen Inc , biopharmaceutical company headquartered inCalifornia, and their collaborators, today publish a study in ...
Ortho Announces Board of Director Appointments
Noted Diagnostic Industry Veteran David B. Perez Joins as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role RARITAN, N.J., Sept. 2, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced thatDav...
Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, Australia
Bridgewest to develop the site into a full-service Contract Development and Manufacturing Organization SAN DIEGO and ADELAIDE, Australia, Sept. 2, 2020 /PRNewswire/ -- The Bridgewest Group, a premier private investment company that focuses on disrupting industries through innovation today announ...
Aqua Medical Announces Final $8.2 Million Equity Investment Led by ShangBay Capital to Close Its $15.5 Million Series A Financing Round
Investment will be used to advance its novel vapor-based ablation system to treat precancerous conditions and metabolic disease such as type 2 diabetes in the gastrointestinal (GI) tract. SANTA ANA, California, Sept. 1, 2020 /PRNewswire/ -- Aqua Medical's innovative platform technology provides ...
Visiopharm raises fresh capital with BankInvest as lead investor
COPENHAGEN, Denmark, Sept. 1, 2020 /PRNewswire/ -- In a new investment round, Visiopharm added BankInvest to the group of institutional investors that already includes ATP, NorthCap, Vækstfonden, and C.L. Davids Fond. BankInvest now holds almost 6% of the equity of the company. All existing inves...
GEN inCode Announces Completion of £3M Institutional Foundation Fundraise
OXFORD, England, Sept. 1, 2020 /PRNewswire/ -- GEN inCode UK Limited, the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the completion of a £3.0M institutional fundraise to internationally scale its prod...
GenScript Biotech Corporation signs exclusive agreement with PH biotech firm to distribute faster, more accurate and more affordable immunity tests for COVID-19
SINGAPORE, Sept. 1, 2020 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) entered an exclusive partnership with Philippines biotech company, IP Biotech. ). This will allow the firm to distribute a breakthrough test kit designed to measure the levels of neutralizing...
Cedrus Group's Chairman Mr. Rani Jarkas Invited to Speak at the ANNUAL BIOPHARMA DEVELOPMENT AND PRODUCTION WEEK
HONG KONG, Sept. 1, 2020 /PRNewswire/ -- The Chairman of Cedrus Group ("Cedrus")
Viva Biotech Announced 2020 Interim Results
Financial Highlights for the 6 months ended June 30, 2020 * Revenue amounted to RMB197.6 million, representing a YOY increase of 38.9% * Gross profit amounted to RMB100.1 million, representing a YOY increase of 39.2%, with Gross profit margin of 50.7% * Adjusted net profit rose to RMB123.7 m...
GenScript Reports 2020 Interim Results and Provides Business Update
NANJING, China, Aug. 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, today reported interim results for the six months endedJune 30, 2020 and provided a corporate update. Revenue of the Group for the six months endedJune 30, 2020 was...
Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference
SAN FRANCISCO and SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune a...
G-ray Switzerland announces new CEO, closes successful funding round
NEUCHÂTEL, Switzerland, Aug. 31, 2020 /PRNewswire/ -- G-ray Switzerland, the medical imaging and industrial diagnosis start-up founded in 2014, has announced the appointment of Luis Pallares as Chief Executive Officer, as the company embarks on an accelerated growth drive and completes a successf...
Million-selling Erba COVID-19 antibody tests now validated on leading ELISA analysers
LONDON, Aug. 31, 2020 /PRNewswire/ -- To improve global availability of high-quality testing methods for SARS-CoV-2,Erba Mannheim announced the availability of validated automated protocols for their successful range of ErbaLisa COVID-19 IgG and IgM ELISA kits. Optimised protocols for popular ins...
Week's Top Stories
Most Reposted
Star-Studded Sponsor Line-up Takes Centre Court at the Singapore Tennis Open 2025
[Picked up by 291 media titles]
2025-01-28 10:49Sephora Unveils Its First Film, "Beauty & Belonging" Celebrating Diversity and Authenticity
[Picked up by 288 media titles]
2025-01-24 08:00Dahua Technology Joins Hands with WWF to Expand Sustainability Efforts Globally
[Picked up by 270 media titles]
2025-01-24 12:15HZICC: Linping Manufacturing Goes Global to Promote City Brand
[Picked up by 266 media titles]
2025-01-24 22:59Sushui Tech to Launch New DMFC Products at Smart Energy Week, Tokyo 2025
[Picked up by 259 media titles]
2025-01-28 09:53